Literature DB >> 22167179

Reciprocal inhibition between the transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1.

So Yong Kim1, Jea-Hyuck Shim, Eunyoung Chun, Ki-Young Lee.   

Abstract

Mitogen-activated protein kinase kinase kinases (MAP3Ks) are activated by a wide spectrum of extracellular stimuli and are involved in various cellular events including proinflammatory and oxidative damage response through activations of two specific transcription factors, nuclear factor κB (NF-κB) and activator protein-1 (AP-1). Although members of the MAP3K family have both overlapping and distinct functions, the inter-regulatory mechanism of MAP3Ks remains largely unknown. In this study we demonstrated that transforming growth factor-β-activated kinase 1 (TAK1)-TAK1-binding protein 1 (TAB1) complex negatively regulates ASK1-mediated signaling, and TAB2 reciprocally regulates TAK1-induced NF-κB and apoptosis signal-regulating kinase 1 (ASK1)-mediated AP-1 activations through the TAK1-TAB2 interaction and the interferences of TAK1-ASK1 interaction. TAK1 interacted with the N or C terminus of ASK1 through the C-terminal TAB2 binding domain of TAK1, with resultant inhibition of ASK1-induced AP-1 activation. Interestingly, the interaction between TAK1 and TAB2 significantly attenuated the ASK1-TAK1 interaction through the competitive interaction with ASK1 to TAK1 and resulted in the activations of TAK1-induced activations of NF-κB and AP-1. More interestingly, H(2)O(2)- and TNF-α-induced apoptosis in TAK1-deficient mouse embryo fibroblast cells were dramatically enhanced by overexpression of ASK1, whereas the apoptosis was markedly inhibited by the overexpression of TAK1. Overall, these results demonstrate that TAK1 and its adapter protein, TAB2, reciprocally regulate both TAK1- and ASK1-mediated signaling pathways to direct the activations of NF-κB and AP-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167179      PMCID: PMC3270992          DOI: 10.1074/jbc.M111.317875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK.

Authors:  C Wang; L Deng; M Hong; G R Akkaraju; J Inoue ; Z J Chen
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

Review 2.  From receptors to stress-activated MAP kinases.

Authors:  H Ichijo
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

3.  Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation.

Authors:  K Sayama; Y Hanakawa; Y Shirakata; K Yamasaki; Y Sawada; L Sun; K Yamanishi; H Ichijo; K Hashimoto
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

Review 4.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

5.  Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis.

Authors:  S Y Kim; E Chun; K-Y Lee
Journal:  Cell Death Differ       Date:  2011-03-18       Impact factor: 15.828

6.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis.

Authors:  K Tobiume; A Matsuzawa; T Takahashi; H Nishitoh; K Morita ; K Takeda; O Minowa; K Miyazono; T Noda; H Ichijo
Journal:  EMBO Rep       Date:  2001-03       Impact factor: 8.807

7.  ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction.

Authors:  Y Mochida; K Takeda; M Saitoh; H Nishitoh; T Amagasa; J Ninomiya-Tsuji; K Matsumoto; H Ichijo
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

Review 8.  MAP3Ks as central regulators of cell fate during development.

Authors:  Evisabel A Craig; Mark V Stevens; Richard R Vaillancourt; Todd D Camenisch
Journal:  Dev Dyn       Date:  2008-11       Impact factor: 3.780

9.  H2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity.

Authors:  So Yong Kim; Hee-Yeon Jo; Mi Hye Kim; Yun-yi Cha; Sung Won Choi; Jae-Hyuck Shim; Tae Jin Kim; Ki-Young Lee
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

10.  Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.

Authors:  Yihui Fan; Yang Yu; Yi Shi; Wenjing Sun; Min Xie; Ningling Ge; Renfang Mao; Alex Chang; Gufeng Xu; Michael D Schneider; Hong Zhang; Songbin Fu; Jun Qin; Jianhua Yang
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

View more
  13 in total

1.  TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-κB.

Authors:  Sae Mi Wi; Gyuyoung Moon; Juhong Kim; Seong-Tae Kim; Jae-Hyuck Shim; Eunyoung Chun; Ki-Young Lee
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

Review 2.  Inflammation- and stress-related signaling pathways in hepatocarcinogenesis.

Authors:  Hayato Nakagawa; Shin Maeda
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

3.  Salt-inducible kinases 1 and 3 negatively regulate Toll-like receptor 4-mediated signal.

Authors:  So Yong Kim; Sookyung Jeong; Kyong-Hwa Chah; Eunyu Jung; Kwan-Hyuck Baek; Seong-Tae Kim; Jae-Hyuck Shim; Eunyoung Chun; Ki-Young Lee
Journal:  Mol Endocrinol       Date:  2013-09-23

4.  Differential roles of ASK1 and TAK1 in Helicobacter pylori-induced cellular responses.

Authors:  Yoku Hayakawa; Yoshihiro Hirata; Hiroto Kinoshita; Kosuke Sakitani; Hayato Nakagawa; Wachiko Nakata; Ryota Takahashi; Kei Sakamoto; Shin Maeda; Kazuhiko Koike
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

5.  S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway.

Authors:  So Yong Kim; Kyung-Hwa Baik; Kwan-Hyuck Baek; Kyong-Hwa Chah; Kyung Ah Kim; Gyuyoung Moon; Eunyu Jung; Seong-Tae Kim; Jae-Hyuck Shim; Matthew B Greenblatt; Eunyoung Chun; Ki-Young Lee
Journal:  Mol Cell Biol       Date:  2013-11-25       Impact factor: 4.272

6.  Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin.

Authors:  Todd D Prickett; Brad Zerlanko; Jared J Gartner; Stephen C J Parker; Ken Dutton-Regester; Jimmy C Lin; Jamie K Teer; Xiaomu Wei; Jiji Jiang; Guo Chen; Michael A Davies; Jeffrey E Gershenwald; William Robinson; Steven Robinson; Nicholas K Hayward; Steven A Rosenberg; Elliott H Margulies; Yardena Samuels
Journal:  J Invest Dermatol       Date:  2013-09-05       Impact factor: 8.551

7.  Ubiquitination of ECSIT is crucial for the activation of p65/p50 NF-κBs in Toll-like receptor 4 signaling.

Authors:  Sae Mi Wi; Jeongho Park; Jae-Hyuck Shim; Eunyoung Chun; Ki-Young Lee
Journal:  Mol Biol Cell       Date:  2014-10-29       Impact factor: 4.138

8.  Cross-talk between Arg methylation and Ser phosphorylation modulates apoptosis signal-regulating kinase 1 activation in endothelial cells.

Authors:  Ming Chen; Xiaosheng Qu; Zhiqing Zhang; Huayu Wu; Xia Qin; Fuji Li; Zhenfang Liu; Liyuan Tian; Jianhua Miao; Wei Shu
Journal:  Mol Biol Cell       Date:  2016-02-24       Impact factor: 4.138

9.  AMP-activated protein kinase-α1 as an activating kinase of TGF-β-activated kinase 1 has a key role in inflammatory signals.

Authors:  S Y Kim; S Jeong; E Jung; K-H Baik; M H Chang; S A Kim; J-H Shim; E Chun; K-Y Lee
Journal:  Cell Death Dis       Date:  2012-07-26       Impact factor: 8.469

10.  Cereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6.

Authors:  Yoon Min; Sae Mi Wi; Jung-Ah Kang; Taewoo Yang; Chul-Seung Park; Sung-Gyoo Park; Sungkwon Chung; Jae-Hyuck Shim; Eunyoung Chun; Ki-Young Lee
Journal:  Cell Death Dis       Date:  2016-07-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.